Correlations between cognitive impairment and brain‑derived neurotrophic factor expression in the hippocampus of post-stroke depression rats

Zhang,Zhao-Hui; Wu,Li-Na; Song,Jing-Gui; Li,Wen-Qiang

doi:10.3892/mmr.2012.1009

Correlations between cognitive impairment and brain‑derived neurotrophic factor expression in the hippocampus of post-stroke depression rats

Authors:
- Zhao-Hui Zhang
- Li-Na Wu
- Jing-Gui Song
- Wen-Qiang Li
View Affiliations

Affiliations: The Second Affiliated Hospital of Xinxiang Medical University, Henan Key Laboratory of Biological Psychiatry, Xinxiang 453002, P.R. China
Published online on: July 26, 2012 https://doi.org/10.3892/mmr.2012.1009
Pages: 889-893

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the correlation between brain-derived neurotrophic factor (BDNF) expression and cognitive impairment in post‑stroke depression (PSD) rats and to explore the mechanism(s) involved in the process of cognitive impairment. A rat model of focal cerebral ischemia was established by occluding the middle cerebral artery (MCA). Rats were subjected to isolation-housing combined with chronic unexpected mild stress (CUMS) to establish a PSD rat model. The learning and memory abilities of the PSD rat model were evaluated by passive avoidance tests. Real‑time PCR and immunohistochemical methods were used to detect changes in BDNF mRNA and protein expression in the hippocampus. Passive avoidance defects were revealed in the PSD and depression groups. Passive avoidance defects were more evident in the PSD group compared with the depression group and the difference was statistically significant (P<0.05). BDNF expression in the hippocampus was significantly lower in the PSD and depression groups compared with that in the normal control group (P<0.01). No significant difference in BDNF expression was identified between the normal control and stroke groups (P>0.05) or between the PSD and the depression groups (P>0.05). The decrease in BDNF expression in the hippocampus of PSD rats may aggravate cognitive impairment, however, the degree of cognitive impairment cannot be reflected by the expression levels of BDNF in the hippocampus.

View Figures

View References

1	Haq SU, Symeon C, Agius M and Brady R: Screening for depression in post stroke patients. Psychiatr Danub. 22:33–35. 2010.PubMed/NCBI
2	Mihara T, Mihara K, Yarimizu J, et al: Pharmacological characterization of a novel, potent adenosine A1 and A2 receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one(ASP5854), in models of Parkinson’s disease and cognition. J Pharmacol Exp Ther. 323:708–719. 2007.PubMed/NCBI
3	Barba R, Martínez-Espinosa S, Rodríguez-García E, Pondal M, Vivancos J and Del Ser T: Post-stroke dementia: clinical features and risk factors. Stroke. 31:1494–1501. 2000. View Article : Google Scholar : PubMed/NCBI
4	Erickson KI, Prakash RS, Voss MW, et al: Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci. 30:5368–5375. 2010.PubMed/NCBI
5	Li G, Peskind ER, Millard SP, et al: Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One. 4:e54242009. View Article : Google Scholar : PubMed/NCBI
6	O’Bryant SE, Hobson VL, Hall JR, et al: Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer’s disease cases. Dement Geriatr Cogn Disord. 31:31–6. 2011.PubMed/NCBI
7	von Bohlen und Halbach O: Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci. 13:22010.PubMed/NCBI
8	Zhou Z, Lu T, Xu G, et al: Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism. Clin Chem Lab Med. 49:185–189. 2011. View Article : Google Scholar : PubMed/NCBI
9	Yang L, Zhang Z, Sun D, et al: Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. Int J Geriatr Psychiatry. 26:495–502. 2011. View Article : Google Scholar : PubMed/NCBI
10	Teixeira AL, Barbosa IG, Diniz BS and Kummer A: Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med. 4:871–887. 2010. View Article : Google Scholar : PubMed/NCBI
11	Murer M, Yan Q and Raisman-Vozari R: Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol. 63:71–124. 2001.
12	McAllister AK: Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci. 58:1054–1060. 2001. View Article : Google Scholar : PubMed/NCBI
13	Mertz K, Koscheck T and Schilling K: Brain-derived neurotrophic factor modulates dendritic morphology of cerebellar basket and stellate cells: an in vitro study. Neuroscience. 97:303–310. 2000. View Article : Google Scholar : PubMed/NCBI
14	Ohira K and Hayashi M: A new aspect of the TrkB signaling pathway in neural plasticity. Curr Neuropharmacol. 7:276–285. 2009. View Article : Google Scholar : PubMed/NCBI
15	Yoshii A and Constantine-Paton M: Post-synaptic BDNF-TrkB signaling in synapse maturation, plasticity and disease. Dev Neurobiol. 70:304–322. 2010.PubMed/NCBI
16	Figurov A, Pozzo-Miller LD, Olafsson P, Wang T and Lu B: Regulation of synaptic responses to high frequency stimulation and LTP by neurotrophins in the hippocampus. Nature. 381:706–709. 1996. View Article : Google Scholar : PubMed/NCBI
17	Cunha C, Brambilla R and Thomas KL: A simple role for BDNF in learning and memory? Front Mol Neurosci. 3:12010.PubMed/NCBI
18	Angelucci F, Mathé AA and Aloe L: Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res. 146:151–165. 2004. View Article : Google Scholar : PubMed/NCBI
19	Almeida RD, Manadas BJ, Melo CV, et al: Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 12:1329–1343. 2005. View Article : Google Scholar : PubMed/NCBI
20	Harper MM, Adamson L, Blits B, Bunge MB, Grozdanic SD and Sakaguchi DS: Brain-derived neurotrophic factor released from engineered mesenchymal stem cells attenuates glutamate- and hydrogen peroxide-mediated death of staurosporine-differentiated RGC-5 cells. Exp Eye Res. 89:538–548. 2009. View Article : Google Scholar
21	Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
22	Xu J, Zhang QG, Li C and Zhang GY: Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic brain injury through TrkB receptor- and calmodulin-mediated PI-3K/Akt pathway activation. Hippocampus. 14:525–537. 2007. View Article : Google Scholar : PubMed/NCBI
23	Tata DA, Marciano VA and Anderson BJ: Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J Comp Neurol. 498:363–374. 2006.PubMed/NCBI
24	Jacobsen JP and Mørk A: Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res. 110:221–225. 2006. View Article : Google Scholar : PubMed/NCBI
25	Numakawa T, Kumamaru E, Adachi N, Yagasaki Y, Izumi A and Kunugi H: Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter. Proc Natl Acad Sci USA. 106:647–652. 2009. View Article : Google Scholar : PubMed/NCBI